Giagounidis, Aristoteles A N <br/><br/>
Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31-q33 with a combination of all-trans-retinoic acid and tocopherol-alpha: a phase II study.  [electronic resource] 

 -  Annals of hematology  Jun 2005 
 - 389-94 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0939-5555 
<br/><br/><label>Standard No.: </label>10.1007/s00277-005-1027-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Bone Marrow--pathology<br/>Chromosome Banding<br/>Chromosome Deletion<br/>Chromosomes, Human, Pair 5--genetics<br/>Drug Eruptions--etiology<br/>Drug Therapy, Combination<br/>Erythropoiesis--drug effects<br/>Follow-Up Studies<br/>Hemoglobins--analysis<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Middle Aged<br/>Myelodysplastic Syndromes--blood<br/>Quality of Life<br/>Treatment Outcome<br/>Tretinoin--administration & dosage<br/>alpha-Tocopherol--administration & dosage